IDO1 and cancer: The intricate metabolic reprogramming within the tumor microenvironment profoundly influences treatment outcomes and patient survival.[11] We observed that Myeloid Derived Suppressor Cells and cancer Associated Fib were negatively correlated with IDO1 expression.